West Pharma (WST) Tops Q1 EPS by 9c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to West Pharma (WST) Tops Q1 EPS by 9c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook

West Announces First-Quarter 2019 Results

April 25, 2019 6:00 AM EDT

EXTON, Pa., April 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.

First-Quarter 2019 Summary (comparisons to prior-year period)

Net sales of $443.5 million grew 7%, organic sales growth was 11% Reported-diluted EPS of $0.73 increased 26% Adjusted-diluted EPS of $0.74 increased 19% Repurchased 800,000 shares... More